Voyager Therapeutics
IPOLeveraging genetics to treat neurological diseases.
Public · Lexington, United States · Founded 2014 · $105.0M raised
- Headquarters
- Lexington, Massachusetts
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- voyagertherapeutics.com
- Total Funding
- $105.0M
- Last Round
- $60.0M Series BApr 2015
- Rounds
- 2
- Type
- Public
About
Voyager Therapeutics is a clinical-stage gene therapy company developing disease-modifying neurotherapeutics for severe neurological diseases. The company leverages validated genetic targets and multiple therapeutic modalities, including its TRACER platform and non-viral approaches, with a pipeline focused on Alzheimer's disease treatments.
Summary
Voyager Therapeutics is a Biotech company based in Lexington, United States, founded in 2014. It has raised $105.0M in total across 2 rounds, most recently a $60.0M Series B round in Apr 2015. Investors include Third Rock Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2015
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...